FRANCISCO JAVIER
GIL BEA
Hospital Sierrallana
Torrelavega, EspañaHospital Sierrallana-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2021
-
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278
2020
-
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262
-
ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage
Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299
2019
-
Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach
Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196
2018
-
Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis
Journal of the Neurological Sciences
-
Retinoids and amyotrophic lateral sclerosis
JAMA Neurology